PHGDH and osteosarcoma: With PHGDH inhibition, the glycolytic rate in osteosarcoma cell lines was increased, demonstrating that, instead of entering de novo serine biosynthesis through 3PG, glucose was shunted through glycolytic intermediates (Figure 2H).